Healthcare -
Biotechnology - NASDAQ - US
$ 8.26
1.23 %
$ 1.22 B
Market Cap
-7.65
P/E
ADPT - REVENUE
Revenue ADPT - Adaptive Biotechnologies Corporation
170 M
LAST VALUE
5.03%
2 YEAR CAGR
25.06%
5 YEAR CAGR
0.00%
10 YEAR CAGR